Heart drug is wrecking my life:The class I killers

Tambocor (flecainide) is one of a group of antiarrhythmics called ‘class I agents’, or sodium-channel blockers. Class II agents are the beta-blockers, and class IV agents are calcium antagonists. Class III drugs are usually prescribed for atrial fibrillation (see Case study, p 8).

The class I drugs are designed to stabilise an irregular heartbeat (arrhythmia) by slowing nerve impulses in the heart, and by anaesthetising heart tissue, making it less sensitive to nerve impulses.

Class I agents are being given to patients for whom the drug was never intended. One report concluded that these drugs are more harmful than helpful in patients recovering from a heart attack (Ann Rev Med, 1994; 45: 119-38).

The Cardiac Arrhythmia Suppression Trial (CAST) had reached a similar conclusion five years earlier when it abandoned its research after finding conclusively that flecainide and encainide, another class I agent, increased death due to arrhythmias and the incidence of cardiac arrest by more than three times the rate with placebo (N Engl J Med, 1989; 321: 406-12).

The CAST results should have radically transformed the use of heart-therapy drugs, but though they did usher in newer and safer agents, the use of class I drugs remains as supreme as ever.

Connection error. Connection fail between instagram and your server. Please try again
What Doctors Don't Tell You Written by What Doctors Don't Tell You

Explore Wellness in 2021